The latest CBD news is here:
- It has been found by a data analytics company that e-commerce sales of CBD have increased during the COVID-19 crisis.
- A new research has found that CBD aids in improving the potential of antibiotics.
- Charlotte’s Web has gained a CBD company that is supported by Rob Gronkowski, a retired NFL tight end .
CBD News Stories
- CBD E-Commerce Sales Increase During COVID-19 Pandemic
- Study: CBD Enhances The Efficacy of Antibiotics
- Charlotte’s Web Bought Rob Gronkowski-Supported CBD Company
CBD E-Commerce Sales Increase During COVID-19 Pandemic
It has been found by, Brightfield Group, a data analytics company, that CBD e-commerce sales have increased during the COVID-19 pandemic.
According to the data from Brightfield Group, online sales for CBD have risen amongst the biggest CBD companies, showing that consumers are using more CBD during the pandemic.
Bethany Gomez, the Managing Director at Brightfield Group, wrote, “Our latest consumer research shows that we can expect higher use, specifically amongst heavier users which is a positive indication of how the market will be going in coming weeks and months.”
It is found by the company that 39% of the users were expecting to use more CBD during this pandemic.
The usage of CBD was most probably to increase by the Gen Z and Millennials consumers with 49% were expecting to use the CBD more.
Brightfield Group also expects a rise in CBD e-commerce trade because of an anticipated increase in depression, anxiety, and insomnia—three of the top four conditions customers consuming CBD for.
Gomez says that a popular topic about CBD and novel coronavirus which came across in social media posts was self-care.
Gomez wrote that CBD self-care products are boosting in this quarantined time as people are returning to self-care luxuries to keep themselves alive or to pass the time.
Study: CBD Enhances the Efficacy Of Antibiotics
It is found in a study from the University of Southern Denmark that the addition of CBD to antibiotics enhances their effectiveness against bacteria.
CBD was added to the antibiotic bacitracin against Staphylococcus aureus bacteria that cause bone infections, heart valve infections, pneumonia, and skin infections
The two combined compounds were more potent than the antibiotic alone.
The study states that the amalgam of bacitracin and CBD is found to be effective against Gram-positive bacteria.
Particularly, the combination actually inhibited the division of the bacteria, hence destabilization of the bacterial membrane, contributing to its destruction.
It is a strategy to find an auxiliary compound for antibiotics for combating increasingly antibiotic-resistant bacteria.
Overuse of antibiotics is the primary cause of antibiotic resistance according to the researchers of this study.
The researcher said that when antibiotic is combined with an auxiliary compound, there would be less need of antibiotic for the inhibition of bacterial growth or destruction as compared to using antibiotic alone. This technique might decrease the chances of development of resistance. Thus it was important to do an investigation to identify the auxiliary compounds.
It was also highlighted by the researchers that “CBD is a quite effectual antimicrobial compound” not only against Staphylococcus aureus but also against other gram-positive bacteria.
A similar study was conducted by the University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions in Brisbane, Australia, in which CBD alone was tested against many gram-positive bacteria.
The researchers found CBD to be “exceptionally effective” against some of the bacteria but advised to do more study.
Charlotte’s Web Bought Rob Gronkowski-Supported CBD Company
Charlotte’s Web, the largest CBD company by market share, has agreed to buy Abacus Health Products, Canadian CBD startup, in $69 million amount.
Abacus owns the brand CBDMedic, which is supported by the former NFL tight end Rob Gronkowski in August of last year, that manufactures over-the-counter CBD topical medications.
According to the agreement, Charlotte’s Web purchases all issued and subordinate voting shares of Abacus.
At the same time, shareholders in will get 0.85 of a common share of Charlotte’s Web for every share they hold in Abacus.
After the announcement of this news on Monday, a rise of five percent was seen in the stock of Charlotte’s Web and 27 percent was observed in Abacus’.
According to the press release, this acquisition establishes “the world’s largest vertically integrated hemp-derived CBD enterprise.”
In a press release, Deanie Elsner, the CEO of Charlotte’s Web said, “The mutual strengths of our relative market positions made this investment a reasonable strategic decision. With this investment, we are reinforcing the business to reflect category evolution. Since most of Abacus’s products are placed in adjacent categories, we have minimal shelf overlap with our combined distribution. Together we are the most progressive CBD company across every segment and channel and placed to enhance our development and expand our market share. Moreover, it allows us to drive greater scale production through our vertically integrated infrastructure.”
The investment “develops the product portfolio of the Charlotte’s Web for the Topicals category,” which is predicted to be the largest CBD product category by 2021, according to data from Brightfield analytical Group.
Perry Antelman, the CEO of Abacus, said, “This project gives our staff and shareholders an unprecedented opportunity in the persuasive influence of the joint ventures. Abacus is one of the leading distributors and suppliers of topical products enriched with hemp extract to the consumers of [food/drug/mass] and healthcare practitioners in the United States. By joining with Charlotte’s Web, we have the ability to accelerate our growth by leveraging the Company’s leading brand, capital markets presence, financial position, infrastructure, expertise, vertical integration, and position the combined Company to bring long-term benefits for our stakeholders.”
There are over 15,000 exclusive retail locations of the company in North America.
